Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
about
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularizationDrug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Photodynamic therapy of experimental choroidal neovascularization in the mouse.Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agentsTargeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesInduction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin.The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion.Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.Strategies for enhanced photodynamic therapy effects.Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer.Synthetic approaches for the conjugation of porphyrins and related macrocycles to peptides and proteins.Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.Accelerating chemical reactions by molecular sledding.
P2860
Q28740612-B89E73B6-8208-4047-9339-670E48334441Q30487756-3ED0D2BE-D521-439A-B47A-3C67A760611FQ33212693-55D6537A-BDD2-4D26-8DF1-F90827747549Q33257172-72DF70AF-673F-4AE6-B6A2-07A8152D35C5Q33279027-0C43EE4F-1999-4A91-ABB7-18CA3F81A30EQ33416828-08285352-97D3-4C97-A95B-A04571DE62A7Q33510871-EA67482F-5E96-4689-95B9-9B2283C0B0B2Q33588136-3C9480FA-4F69-4720-BFF3-8FEAF3C70128Q33664307-669270B2-63CC-4DFF-893B-5E2DDC284F1DQ35508023-40CFC41F-7940-4857-AEA2-340B065E8489Q35645574-320915A2-4635-40DC-9CC8-663A0B527762Q35766780-CFDA9F42-6336-4CAC-9C14-53866E266E69Q36945978-E37C3C63-F600-4B21-B955-AADE42000238Q37284363-11C82EE2-DD07-4144-BA91-C5B08CD8DE90Q37860172-3463D437-820E-4FCA-BB91-47261DEF3374Q42528833-5E8286E1-6AF4-4C3F-AEAF-7517890847B0Q53264839-D2489653-2969-47C1-9CBF-AA01BFBBA29B
P2860
Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Selective photodynamic therapy ...... lial growth factor receptor-2.
@ast
Selective photodynamic therapy ...... lial growth factor receptor-2.
@en
type
label
Selective photodynamic therapy ...... lial growth factor receptor-2.
@ast
Selective photodynamic therapy ...... lial growth factor receptor-2.
@en
prefLabel
Selective photodynamic therapy ...... lial growth factor receptor-2.
@ast
Selective photodynamic therapy ...... lial growth factor receptor-2.
@en
P2093
P1433
P1476
Selective photodynamic therapy ...... lial growth factor receptor-2.
@en
P2093
Evangelos S Gragoudas
Makhluf J Haddadin
Norman A Michaud
Reem Z Renno
Yoshiko Terada
P304
P356
10.1001/ARCHOPHT.122.7.1002
P407
P50
P577
2004-07-01T00:00:00Z